Mary and Deryl Hart Distinguished Professor of Surgery Duke University School of Medicine Durham, North Carolina, United States
Disclosure(s):
E. Shelley Hwang, MD, MPH: Exai Bio: Advisor (Ongoing)
The role of neoadjuvant therapy for patients with both invasive cancer and pre-malignant breast disease is rapidly evolving. The purpose of this session is to review current data and ongoing trials to provide guidance on breast cancer treatment, including specific immunotherapies and surgical timing.